PERRY's RECENT ACQUISITIONS INCLUDE 12-STORE DRUG CHAIN and two auto parts firms, Perry announced Sept. 24. Within its Michigan base, Perry increased its penetration of the Flint area market with the purchase of Cook Drug. The acquisition included Cook's health care product supply operation, Flint Medical & Surgical Supply. Perry said Cook has annual sales of about $20 mil. The two autoparts houses, the three-store Pappy's Discount Auto Parts and the 22-store Jack Lampert-Singer Super Auto Parts stores, are both located in the St. Louis area. Perry noted that the purchases move the business into its seventh state, Missouri. Competition for small chain acquisitions in Michigan has been heating up in recent months. Rite Aid has aggressively been pursuing purchases in the state. Rite Aid recently announced the purchase of Reeme's Drug Stores, a five-unit chain based in Grand Rapids, with sales in the $7.5 mil. range. The terms were not disclosed. Reemes previously had been involved in acquisition discussions with Perry. Perry maintained that Reemes signed a letter of intent in June. The Reemes purchase is Rite Aid's third acquisition in Michigan within the last few months. The firm bought the 24-store Muir Drug chain in June and the six-store Herrlich Drug chain in August, for a total for 35 Rite Aid stores in Michigan. Rite Aid also announced acquisition of the 14-store Lippert Drug Store chain in Lowell, Pa. Sept. 10.
Join thousands of industry professionals who rely on Pink Sheet for daily insights
Already a subscriber?
Advanz Pharma would have had to show that the European Commission’s decision to revoke Ocaliva’s conditional marketing approval risked causing serious and irreparable harm, according to lawyers from Van Bael & Bellis.
This is your final call to participate in the survey to better understand our subscribers’ content and delivery needs. The deadline is 20 September.
We are conducting a survey to better understand our subscribers’ content and delivery needs. If there are any changes you’d like to see in coverage topics, article format, or the method in which you access the Pink Sheet – or if you love it how it is – now is the time to have your voice heard.
A new pilot aims to take Brazil closer to ‘digital transformation.’
Recent and upcoming US FDA advisory committee meetings and a summary of the topics covered.
The UK’s research-based pharma industry and medical research charities have set out clear action points to drive greater diversity and inclusion in clinical trials.
Blenrep, GSK’s multiple myeloma therapy, faced a major setback when it was withdrawn from the market in 2022. The drug has since made a return as a second-line therapy, and is on track to being reimbursed in England.
